Li Jia, Paulus Yannis M, Shuai Yuanlu, Fang Wangyi, Liu Qinghuai, Yuan Songtao
Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
J Ophthalmol. 2017;2017:4936924. doi: 10.1155/2017/4936924. Epub 2017 Mar 12.
For years, branch retinal vein occlusion is still a controversial disease in many aspects. An increasing amount of data is available regarding classification, pathogenesis, risk factors, natural history, and therapy of branch retinal vein occlusion. Some of the conclusions may even change our impression of branch retinal vein occlusion. It will be beneficial for our doctors to get a deeper understanding of this disease and improve the treatment skills. The aims of this review is to collect the information above and report new ideas especially from the past a few years.
多年来，视网膜分支静脉阻塞在许多方面仍是一种存在争议的疾病。关于视网膜分支静脉阻塞的分类、发病机制、危险因素、自然病程及治疗，已有越来越多的数据。其中一些结论甚至可能改变我们对视网膜分支静脉阻塞的印象。这将有助于我们医生更深入地了解这种疾病并提高治疗技能。本综述的目的是收集上述信息，并报告特别是过去几年的新观点。
